Predictors of Hospital Mortality in the Thrombolytic Era for Acute Myocardial Infarction in Salvador (BA) - Brazil;Preditores de Mortalidade Hospitalar na Era Trombolítica para o Infarto Agudo do Miocárdio em Salvador (BA)

Arquivos Brasileiros de Cardiologia

Volumn 68, Issue 4, 1997, Pages 249-255

  Passos, Luiz Carlos Santana ^a,b   Lopes, Antonio Alberto ^a   De Souza, Carlos Alfredo Marcílio ^a   De Almeida Souza, José Antônio ^a   De Souza Neto, João Pondé ^a   Fo, João Souza ^a   Feitosa, Gilson ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Acute myocardial infarction; Hospital mortality; Thrombolytic therapy

Indexed keywords

AGED; ARTICLE; BRAZIL; CHI SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

AGED; BRAZIL; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THROMBOLYTIC THERAPY;

EID: 0031107870     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Biasil Ministério da Saúde Coordenação de Doenças Cardiovasculares. Doenças Cardiovasculares no Brasil. Sistema Único de Saud́e-SUS. Brasília, 1993
2. Brasil Ministério da Saúde Fundação Nacional de Saúde CENEPI Informe Epidemiológico do SUS 1992; 4. 92-142.
3. ISIS-1 (First International Study of Infarct Survival) Collaborative Group - Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. ISIS-1 Lancet 1986; 2 57-66
4. ISIS-2 - Randomized trial of intravenous streptoquinase, oral aspirin, both or neither among 17187 cases suspected acute myocardial infarction. Lancet 1988; 2 349-60
5. The GUSTO investigators - An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction N Eng J Med 1993, 329: 673-82
6. Grines CL, Browne KF, Marco J - For the primary angioplasty in myocardial infarctionstudy group A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction N Engl J Med 1993, 328. 673-9.
7. McGovern PG, Pankow JS, Shahar E, Doliszny K, Folsom A, Luepker RV for the Minnesota Heart Survey Investigatores - Recent trends in acute coronary heart disease mortality, morbidity, medical care and risk factors N Engl J Med 1996, 334 884-90
8. Greenbaum RA, Morris R, Sritara P, Shanit D, Chan KL - Reduced in hospital moitality from acute myocardial infarction with general adoption of thrombolytic treatment in the North West Thames health region 1979-1991 Br Heart J 1995, 74: 493-6
9. Ranjadayalan K, Umachandran V, Timmis A - Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit Am J Med 1992, 92 233-8
10. Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK - Changes in acute myocardial infarction risk and patterns of practice for patients older and yonger than 70 years, 1987-90 Can J Cardiol 1992; 8 : 596-600
11. Erricson CG, Lindvall B, Olsson G et al - Trends in coronary care. A retrospective study of patients with myocardial infarction treated in coronary units. Acta Med Scand 1988, 224 507-13.
12. Lessa I, Cortes E, Souza JA, Souza Fo J, Ponde Netto J, Almeida FA - Epidemiology of acute myocardial infarction in Salvador, Brazil incidence, lethality and mortality PAHO 1987, 21: 28-37
13. Sociedade Brasileira de Cardiologia Consenso sobre tratamento do pós-infarto do miocárdio Arq Bras Cardiol 1995, 64: 273-80.
14. Sociedade Brasileira de Cardiologia Consenso brasileiro sobre trombólise Arq Bras Cardiol 1994: 63(supl II) 1-8
15. Tunsdall-Pedoe H - Monitoring trends in cardiovascular disease and risk factors the WHO "MONICA" Project WHO Chronicle 1985 39 3-5
16. Mascioli S, Jacobs D, Kottke T - Diagnostic criteria for hospitalized acute myocardial infarction: the Minnesotaperience Int J Epidemiol 1989, 18 76-83
17. Polanczyk CA, Prado K, Borges MS, Ribeiro JP - Infarto agudo do miocárdio na era trombolitica: elevada mortalidade em pacientes idosos Rev Ass Mcd Brasil 1993, 39 65-72
18. Tarkieltaub E - Avaliação da terapia trombolitica sobre a mortalidade em pacientes internados em UTI adulte de Hospital Municipal Arq Bras Cardiol 1995, 64: 345-6
19. Lee KL, Woodlief LH, Topol E for the GUSTO-1 Investigatores - Predictors of 30-day in the era of reperfusion for acute myocardial infarction - results from an international trial of 41021 patients. Circulation 1995; 91 1659-68.
20. Barbash GI, Mondan M, Goldbourt U, White H, Van der Werf F, for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial - Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profile J Am Coll Cardiol 1993, 21: 281-6
21. Tsuyuki RT, Teo KK, Ikuta RM, Bay KS, Greenwood PV, Montague TJ - Mortality risk and patterns of practice in 2070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex and medical therapy Chest 1994, 105: 1687-92
22. Maynard C, Weaver WD, Litwin PE et al for the MITI Project Investigators - Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the myocardial infarction triage and intervention project). Am J Cardiol 1993; 72: 877-82
23. Dubois C, Pierard LA, Albert A et al - Short-term risk stratification at admission based on simple clinical data in acute myocardial infarction Am J Cardiol 1988, 61 216-19.
24. Col NF, Gurwitz JH, Alpert JS, Goldberg RJ - Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy. Am J Cardiol 1994, 73 149-57.
25. Bates ER, Topol EJ - Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991; 18: 1077-84
26. Feldman T, Hinkle RC, Ziegler JW - Direct percutaneos transluminal coronary angioplasty for patients with exclusions from thrombolysis Am Heart J 1994; 127 1220-5
27. Clarke KW, Gray D, Keating NA, Hampton JR - Do women with acute myocardial infarction receive the same treatment as men. Br Med J 1994; 309: 563-6.
28. Gurwitz JH, Osganian V, Goldberg R, Chen Zuoyao, Gore JM, Alpert J - Diagnostic testing in acute myocardial infarction: Does Patient age influence utilization patterns? The Worcester Heart Attack Study. Am J Epidemiology 1991, 134: 948-57
29. Maynard C, Althouse R, Cerqueira M, Olsiifka, Kennedy JW - Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction. Am J Cardiol 1991; 68: 529-30
30. Eaker E, Chesebro JH, Sacks F, Wenger NK, Whisnant JP, Winston M - Cardiovascular disease in women Circulation 1993; 88: 1999-2009.
31. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI - Sex differences in mortality after myocardial infarction. Circulation 1995; 91: 1861-71.
32. Sobel BE - Coronary thromboysis and the new biology J Am Coll Cardiol 1989; 14 850-8
33. Goidberg RJ, Gore JM, Alpert JS et al - Cardiogenic shock resulting from acute myocardial infarction: a fourtenn year community wide perspective. N Engl J Med 1991; 325 1117.